您的位置: 首页 > 农业专利 > 详情页

Therapeutic Uses of CD137pos Regulatory T Cells in Treating Autoimmune Diseases
专利权人:
University of Cincinnati
发明人:
William Ridgway,David Erwin Adams,Kritika Kachapati
申请号:
US15615183
公开号:
US20170274043A1
申请日:
2017.06.06
申请国别(地区):
US
年份:
2017
代理人:
摘要:
A method for treating or preventing a T-cell-mediated autoimmune disease is provided herein, the method including administering to a mammal in need thereof a therapeutically effective amount of soluble CD137 or CD137pos regulatory T cells. Also provided are pharmaceutical compositions for treating or preventing T-cell-mediated autoimmune diseases, the pharmaceutical compositions including a therapeutically effective amount of soluble CD137 or CD137pos regulatory T cells and a pharmaceutically-acceptable carrier.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充